Dapansutrile Ameliorates Atrial Inflammation and Vulnerability to Atrial Fibrillation in HFpEF Rats

This study aimed to analyse the effect of pharmacological inhibition of NLRP3 inflammasomes using dapansutrile (DAPA), an oral NLRP3-specific inhibitor.

Source: Heart, Lung and Circulation - November 30, 2023 Category: Cardiology Authors: Hongjie Yang, Jun Zhu, Hui Fu, Wei Shuai Tags: Original Article Source Type: research